Authors:
RONEN D
SCHWARTZ D
TEITZ Y
GOLDFINGER N
ROTTER V
Citation: D. Ronen et al., INDUCTION OF HL-60 CELLS TO UNDERGO APOPTOSIS IS DETERMINED BY HIGH-LEVELS OF WILD-TYPE P53 PROTEIN WHEREAS DIFFERENTIATION OF THE CELLS ISMEDIATED BY LOWER P53 LEVELS, Cell growth & differentiation, 7(1), 1996, pp. 21-30
Citation: Y. Teitz et al., INHIBITION OF FELINE IMMUNODEFICIENCY VIRUS PRODUCTION AND HIV TAT ACTIVITY BY THIOSEMICARBAZONE DERIVATIVES, Antiviral chemistry & chemotherapy, 5(4), 1994, pp. 229-235
Citation: R. Mamet et al., TRANSFORMATION, GROWTH-RATE, AND THE HEME BIOSYNTHETIC-PATHWAY IN V-ABL-TRANSFECTED FIBROBLASTS, Biochemical medicine and metabolic biology, 52(1), 1994, pp. 53-57
Authors:
TEITZ Y
RONEN D
VANSOVER A
STEMATSKY T
RIGGS JL
Citation: Y. Teitz et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY N-METHYLISATIN-BETA' 4'-DIETHYLTHIOSEMICARBAZONE AND N-ALLYLISATIN-BETA-4'/4'-DIALLYTHIOSEMICARB/, Antiviral research, 24(4), 1994, pp. 305-314
Citation: Y. Teitz et al., RELATIONSHIPS BETWEEN STRUCTURE AND ANTIRETROVIRAL ACTIVITY OF THIOSEMICARBAZONE DERIVATIVES, Chemotherapy, 40(3), 1994, pp. 195-200
Citation: Y. Teitz et al., SELECTIVE REPRESSION OF V-ABL-ENCODED PROTEIN BY N-METHYLISATIN-BETA-4',4'-DIETHYLTHIOSEMICARBAZONE AND N-ALLYLISATIN-BETA-4',4'-DIALLYLTHIOSEMICARBAZONE, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2483-2485